Deepa Dhawan
Overview
Explore the profile of Deepa Dhawan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ganguly S, Srivastava R, Agarwala S, Dwivedi S, Gupta Bansal P, Gonmei Z, et al.
Clin Nutr
. 2022 Jun;
41(7):1501-1511.
PMID: 35667266
Background & Aims: Impact of micronutrient deficiency on childhood malignancy is unexplored. We estimated the prevalence of baseline micronutrient deficiency in children with cancer and its impact on event-free survival...
2.
Pramanik R, Agarwala S, Sreenivas V, Dhawan D, Bakhshi S
BMJ Support Palliat Care
. 2021 Jan;
13(2):234-237.
PMID: 33468507
Objective: Health-related quality of life (HRQoL) is an important outcome for paediatric cancer studies. We compared the HRQoL between patients of progressive paediatric solid tumours randomised to metronomic chemotherapy versus...
3.
Sharma A, Ganguly S, C S, Pillai A, Dhawan D, Sreenivas V, et al.
BMJ Support Palliat Care
. 2020 Oct;
13(e1):e156-e162.
PMID: 33122168
Objectives: More than 50% patients develop emesis during induction therapy for acute myeloid leukaemia (AML). The addition of aprepitant for emesis control in children receiving induction for AML have not...
4.
Naik R, V S, Singh V, Pillai A, Dhawan D, Bakhshi S
J Clin Oncol
. 2020 Sep;
38(32):3785-3793.
PMID: 32931400
Purpose: Chemotherapy-induced nausea and vomiting (CINV) is a significant toxicity of chemotherapy. Olanzapine is recommended in adult patients for the prevention of CINV but has not been prospectively investigated in...
5.
Bansal A, Sharawat S, Gupta R, Vishnubhatla S, Dhawan D, Bakhshi S
Am J Blood Res
. 2020 Sep;
10(4):90-96.
PMID: 32923088
Background: Regulatory T cells (Tregs) modulate immune system by suppressing other immune cells. In current exploratory era of immunotherapy, the detailed enumeration data of Tregs cells in pediatric AML is...
6.
Pramanik R, Tyagi A, Agarwala S, Vishnubhatla S, Dhawan D, Bakhshi S
Indian Pediatr
. 2020 Mar;
57(6):508-511.
PMID: 32221052
Objective: We compared Vascular Endothelial Growth factor (VEGF) and Thrombospondin-1 between patients with progressive paediatric malignancies randomized to metronomic chemotherapy versus placebo to determine their role as biomarker. Methods: In...
7.
Srivastava R, Gupta V, Dhawan D, Geeta K, Bakhshi S
J Psychosoc Oncol
. 2019 Mar;
36(5):658-666.
PMID: 30862311
Purpose: To determine the prevalence of poor food knowledge and food restrictions among families of children with cancer and assess their impact on nutritional outcomes. Methods: In this cross-sectional study...
8.
Pramanik R, Agarwala S, Gupta Y, Thulkar S, Vishnubhatla S, Batra A, et al.
JAMA Oncol
. 2017 Apr;
3(9):1222-1227.
PMID: 28384657
Importance: Although oral metronomic chemotherapy is often used in progressive pediatric solid malignant tumors, a literature review reveals that only small single-arm retrospective or phase 1 and 2 studies have...
9.
Srivastava R, Batra A, Dhawan D, Bakhshi S
Pediatr Hematol Oncol
. 2017 Mar;
34(1):29-35.
PMID: 28287332
Increased obesity in leukemia survivors has been attributed to chemotherapy and radiation. Data on total energy intake (TEI) and total energy expenditure (TEE) are lacking in obese childhood leukemia patients...
10.
Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, et al.
J Nucl Med
. 2016 Oct;
58(4):577-583.
PMID: 27754902
Data about the significance of F-FDG PET at interim assessment and end of treatment in pediatric Hodgkin lymphoma (HL) are limited. Patients (≤18 y) with HL were prospectively evaluated with...